[HTML][HTML] Beyond the adverse effects of the systemic route: exploiting nanocarriers for the topical treatment of skin cancers
B da Silva Gomes, AC Paiva-Santos, F Veiga… - Advanced Drug Delivery …, 2024 - Elsevier
Skin cancer is a heterogeneous disease that can be divided into two main groups,
melanoma and nonmelanoma skin cancers. Conventional therapies for skin cancer have …
melanoma and nonmelanoma skin cancers. Conventional therapies for skin cancer have …